Quotables
"What, sir, would you make a ship sail against the wind and currents by lighting a bonfire under her deck? I pray you, excuse me, I have not the time to listen to such nonsense."
Napoleon Bonaparte ; When told of the Robert Fulton steamboat
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Application No. | Application Title | Issue Date |
| 20120053134 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURONAL DAMAGE AND NEUROLOGICAL DISEASES The present invention relates to a pharmaceutical composition for preventing or treating neuronal damage and neurological diseases, and more particularly, to a pharmaceutical composition for preventing or treating neuronal damage and neurological diseases containing, as... | 03/01/2012 |
| 20120034294 | METHOD OF MAKING SMALL LIPOSOMES Liposomes of constrained particle size are prepared by substantially continuously mixing substantially continuously flowing streams of water, and of an organic solvent contain lipid(s) capable of forming liposomes, and cooling the mixture so liposomes form, the ratio of... | 02/09/2012 |
| 20110250208 | Oxidized Cardiolipin as a Novel Pro-Inflammatory Factor Low levels of antibodies reactive with oxidised Cardiolipin (oxCL) in mammals are related to an increased risk of developing cardiovascular diseases, auto-immune diseases or inflammatory conditions. High levels can have a protective function and in general there is a ne... | 10/13/2011 |
| 20110183421 | COMPOSITION AND METHOD FOR CONVERTING A NON-PATHOGENIC PRION PROTEIN INTO A PATHOGENIC CONFORMATION AND USES THEREOF Described herein is a composition for converting a non-pathogenic prion protein (“PrPN”) into a prion protein in a pathogenic conformation (“PrPPath”) comprising a lipid and a polyanion. Also described are methods of (1) using the compositi... | 07/28/2011 |
| 20110040108 | INOSITOLPHOSPHOLIPIDS AND ANALOGUES PHOSPHATIDYLINOSITOL PRODUCTS AND PROCESSES Embodiments of the invention relate to natural and synthetic inositolphospholipid (IPL) materials, their preparation and applications. They provide compositions of the parent IPL comprising phosphatidylinositol (PI), PI-phosphates (phosphoinositides) and derivatives and... | 02/17/2011 |
| 20100316680 | ANTI-INFLAMMATORY PROPERTIES OF MARINE LIPID COMPOSITIONS Novel marine lipid compositions comprising triglycerides and omega-3 rich phospholipids are described. The compositions are characterized by providing highly bioavailable omega-3, increased tissue incorporation of omega-3 and reduced concentration of pro-inflammatory cy... | 12/16/2010 |
| 20100317622 | Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids The present invention provides a method of efficiently and stably producing LCPUFA-PL. Specifically, the invention provides a method for producing phospholipids that contain LCPUFA as a constituent (LCPUFA-PL), wherein lipid producing cells producing lipids that contain... | 12/16/2010 |
| 20100286073 | COMPOUNDS AND METHODS FOR PHARMACEUTICAL USE The present invention relates to compounds, as well as to compositions, methods and kits comprising such compounds, for use in the treatment or prophylaxis of fibromyalgia, chronic fatigue syndrome, myofascial pain syndrome, Gulf War syndrome and related conditions, whe... | 11/11/2010 |
| 20100279985 | LIVER FUNCTION-PROTECTING AGENT Disclosed is a liver function-protecting agent which comprises a phospholipid as an active ingredient, and which can exhibit an excellent prophylactic and ameliorating effect on the deterioration in the liver function when ingested orally. Also disclosed is a liver func... | 11/04/2010 |
| 20100166838 | Methods And Compositions For Modulating Keratinocyte Function The disclosure is generally directed to methods and compositions for modulating keratinocyte function, more particularly, to compositions and methods for normalizing keratinocyte proliferation and differentiation, compositions and methods for modulating levels of phosph... | 07/01/2010 |
| 20100076209 | PEG-lipid conjugates for liposomes and drug delivery New diacylglycerol-polyethylene glycol (DAG-PEG) conjugates are described. A variety of linkers between the PEG chain and glycerol backbone of the DAG-PEGs may be selected to optimize liposomal formulations of pharmaceuticals and cosmetics.... | 03/25/2010 |
| 20100063135 | POLYETHYLENE GLYCOL LIPID CONJUGATES AND USES THEREOF Polyethylene glycol (PEG)-lipid conjugates, polyethylene glycol (PEG)-lipid conjugate based drug delivery systems, ways to make them and methods of treating diseases using them are disclosed.... | 03/11/2010 |
| 20100036141 | PROCESSES FOR THE PREPARATION OF PHOSPHATIDES The present invention discloses processes for the preparation of phosphatides and salts thereof, the processes including the steps of using at least one raw material lecithin as a substrate and a water-insoluble surfactant-matrix material having a particulate size great... | 02/11/2010 |
| 20100034814 | COMPOSITIONS AND METHODS FOR BINDING LYSOPHOSPHATIDIC ACID Compositions and methods for making and using anti-LPA agents, for example, monoclonal antibodies, are described. Variable domain and complementarity determining region amino acid sequences of several monoclonal antibodies against LPA are disclosed, as is a consensus an... | 02/11/2010 |
| 20090253923 | Preparation of glycerol derivatives ad intermediates therefor Disclosed is a process for the regioselective preparation of glycerol derivative in a high efficiency and yield. The process for the regioselective preparation of 1-R1-2-R2-3-acetyl-glycerol derivative comprises the steps of: obtaining 1-R1 10/08/2009 | |
| 20090202619 | POLYOXYALKYLENE CHAIN-CONTAINING LIPID DERIVATIVE AND LIPID FILM STRUCTURE CONTAINING SUCH DERIVATIVE A polyoxyalkylene chain-containing lipid derivative, which is represented by the following formula (1): wherein L, Y, W, X1, X2, X3, OA, Z, m1, m2, m3, n1, n2 and n3 are as de... | 08/13/2009 |
| 20080166781 | Production of Polyunsaturated Fatty Acids Using Novel Cell Treatment Method A method for isolating one compound or more than one compound from a biomass which contains microorganisms that have produced the compound or compounds, the method comprising the following steps: (a) preparing or obtaining wet cells having an average moisture content of... | 07/10/2008 |
| 20080020124 | Producing Method of Phospholipids Including Long-Chain Polyunsaturated Fatty Acids as Constituents, and Use of Such Phospholipids The present invention provides a method of efficiently and stably producing LCPUFA-PL. Specifically, the invention provides a method for producing phospholipids that contain LCPUFA as a constituent (LCPUFA-PL), wherein lipid producing cells producing lipids that contain... | 01/24/2008 |
| 20070224255 | Liposomal Formulations The invention relates to formulations of hydrophilic substances encapsulated in liposomes, to the method of encapsulation of the hydrophilic substances in the liposomes and the use of said formulations in the prevention and/or treatment of diseases and/or disorders in h... | 09/27/2007 |
| 20050181037 | Cardiolipin compositions their methods of preparation and use The invention provides new synthetic routes for cardiolipin with different fatty acids and/or alkyl chains with varying chain length and also with or without unsaturation. The reaction schemes can be used to generate new forms of cardiolipin, including cardiolipin varia... | 08/18/2005 |
| 20050020543 | Hexa-citrated phytate and process of preparation thereof The present invention relates to a new chemical compound known as hexa-citrated phytate and a method of production thereof. The new chemical compound has six citrate molecules attached at the hydroxyl group of a citric acid to phosphates of a phytate molecule. This new ... | 01/27/2005 |
